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Abstract
Introduction. Patients with anorexia nervosa (AN) are at increased risk of ventricular arrhythmias, which are considered 
to be associated with QT interval prolongation. The aims of this study was to analyze the QT interval in patients with AN 
considering the potential impact of pharmacotherapy and to verify various QT correction formulas.
Materials and methods. Fifty-six patients hospitalized with AN (average age: 22.8 ± 5.6 years; female/male: 54/2, 
mean body mass index = 13.6 ± 2.6 kg/m2) were enrolled in analysis: group non-D (n = 44; 78.6%) included patients 
who did not use drugs that prolong the QT interval, group D (n = 12; 21.4%) included patients who were treated with 
such drugs. QT intervals were measured in a 12-lead electrocardiogram and corrected using the four formulas: Bazett, 
Fridericia, Framingham and Hodges.
Results. Mean heart rate (HR) was similar in both groups (61 ± 16.3 bpm in group D vs. 63.1 ± 18.7 bpm in non-D, 
p > 0.05). Pathological bradycardia (HR < 50 bpm) was present in 5 patients (41.7%) in group D and in 13 patients 
(29.5%) in group non-D. QTc interval corrected with Framingham formula was longer in group-D (459 ± 81 ms) vs. non-D 
group (413 ± 33 ms), p = 0.04. QT interval corrected with Bazett and Hodges formulas was significantly dependent on 
HR (R = –0.29, p = 0.03 and R = –0.42, p = 0.001, respectively). Influence of HR on results of Fridericia and Framing-
ham formulas was not significant (R = –0.22, p = 0.1 and R = –0.11, p = 0.4).
Conclusions. Information about pharmacotherapy in AN patients is key for QTc assessment. Choice of correction formula 
has impact on the QTc. QTc obtained using Framingham and Fridericia formulas were the least dependent on heart rate.
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prolong the QT interval. Demographic and clinical data at 
admission were analyzed.
Drug classification
To assess drug’s potential to prolong QT interval and indu-
ce torsades de pointes (TdP), classification system from 
CredibleMeds was used [8]. Group D consisted of patients, 
who were taking drugs with:
 — known risk of TdP — cisapride (n = 1);
 — possible risk of TdP — mianserin (n = 2), mirtazapine 
(n = 1);
 — conditional risk of TdP (under certain condition like 
electrolyte imbalance, drugs interaction) — fluoxetine 
(n = 1), sertraline (n = 2), olanzapine (n = 1), diuretics 
with omeprazole (n = 3), hydroxyzine (n = 1).
Electrocardiography
The standard 12-lead ECGs at rest were recorded (paper 
speed 25 mm/s, 10 mm/mV) at admission. Analyses of 
ECG recordings were performed by single, experienced car-
diologist. We measured QT intervals looking for the longest 
and shortest ones to calculate QT dispersion (QTd). Results 
were corrected using the four commonly used formulas:
 — Bazett: QTc = QT / √RR [9]
 — Fridericia: QTc = QT / 3√RR [10]
 — Framingham: QTc = QT + 0.154 × (1 – RR) [11]
 — Hodges: QTc = QT + 1.75 × (HR – 60) [12]
QT and QTc interval prolongation was defined as QT or 
QTc duration in women > 460 ms and in men > 450 ms [13].
Statistical analysis
All statistical analyses were performed using Statistica 
version 13 (TIBCO Software Inc., Palo Alto, California, United 
States). The continuous variables were expressed as the 
mean ± standard deviation or median and 1–3 quartile 
boundaries and the categorical variables as the number 
and percentage of subjects. The normality of distribution 
was verified with the Shapiro-Wilk test. Differences between 
any unpaired normally distributed samples were calculated 
using the Student’s t-test, while the non-normal data were 
compared using the Mann-Whitney U test. The Wilcoxon 
signed-rank test was used for paired data (within group). 
Differences in categorical variables were assessed using 
the Fisher’s exact test. The Spearman’s rank correlation 
coefficient was used for testing the strength of the cor-
relation between two variables. A p value of < 0.05 was 
considered to be significant.
Results
Demographic and clinical data
A total of 56 patients were incorporated into study. Detailed 
demographic and clinical characteristic of study population 
was presented in Table 1 as well as comparison of two 
Introduction
Anorexia nervosa (AN) is a severe, often deadly, eating 
disorder that leads to cachexia and many somatic compli-
cations [1]. Among mental disorders, AN has the highest 
mortality and, according to current data, about 10 percent 
of patients die from sudden cardiac death (SCD) [2].
Increased risk of SCD in AN is due to many negative 
factors occurring in the course of the disease that dama-
ge the cardiovascular system [1].
Sinus bradycardia is quite commonly observed in pa-
tients with AN [3], while the most common reasons of SCD 
are serious ventricular arrhythmias (such as ventricular ta-
chycardia or ventricular fibrillation). Probability of ventricu-
lar arrhythmia increases with changes in repolarization of 
the ventricular muscle, what is reflected by the changes in 
the electrocardiogram (ECG). The most common changes 
associated with an increased risk of SCD in this group of 
patients are QT prolongation [4, 5] or QT shortening. Most 
reports on QT interval in AN are based on measurement 
of QT interval without correction or with correction using 
the Bazett formula, which is not recommended for patients 
with bradycardia [6], and these are often people with AN. 
An important factor causing the frequent occurrence of QT 
abnormalities in this group are the drugs used by these 
patients, which may affect the QT interval and have a pro-
arrhythmic effect [7]. Most papers on this subject do not 
consider the impact of the drugs used by patients on the 
obtained results and in this group of patients this is parti-
cularly important. An example is that these patients often 
use e.g. antidepressants, many of which have a documen-
ted negative effect on the cardiovascular system, which is 
reflected by changes in the ECG.
The aims of this study was to analyze the QTc interval in 
patients with AN considering the potential impact of phar-
macotherapy on the QTc interval and to verify various QT 
correction formulas.
Materials and method
This is a retrospective, single-center study. Data of 64 con-
secutive adult patients with anorexia nervosa hospitalized 
in the Department of Internal Medicine and Metabolic 
Diseases of the Medical University of Silesia between 
2002 and 2017 were screened. The exclusion criteria 
were lack of ECG at admission, family history of long QT 
syndrome or sudden cardiac death, left or right bundle 
branch blocks, paced rhythms, repeated hospitalizations 
(only first hospitalization of each patient was taken into 
consideration). The final analysis included 56 patients who 
were divided into two groups: group non-D (n = 44; 78.6%) 
consisted of patients who did not use drugs that prolong 
the QT interval, group D (n = 12; 21.4%) included patients 
who had chronic pharmacotherapy with drugs that may 
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groups. The mean age was 22.8 ± 5.6 years. High female 
predominance was observed [female/male (F/M): 54/2]. 
Sodium level was lower and glucose level was higher in 
group D than in group non-D. No other differences were 
observed in laboratory findings.
ECG analysis
Sinus rhythm was present in all ECG. Mean heart rate (HR) 
was similar in both groups (61 ± 16.3 bpm in group D vs. 
63.1 ± 18.7 bpm in non-D, p > 0.05). Pathological brady-
cardia (HR < 50 bpm) was observed in 5 patients (41.7%) 
in group D and in 13 patients (29.5%) in group non-D, 
p > 0.05. The mean QTd did not differ between group D 
and non-D (40 ms vs. 36.8 ms, respectively, p > 0.05).
QTc interval prolongation was found in 2 to 4 patients 
(16.7–33.3%) in D-group and in 3 to 5 patients (6.8–11.4%) 
in non-D group depending on correction formula. The per-
centage was significantly greater in group D than in group 
non-D when Fridericia formula was used. QTc interval ten-
ded to be longer in Group-D: 459 ± 81 ms vs. 413 ± 33 ms, 
p = 0.04, correction with Framingham formula, and border-
line p values (0.05–0.07) was found for others (Table 2).
QTc interval prolongation over 500ms was present in 
5 patients (all female) — 3 in group D and 2 in group non-D 
(25% vs. 4.5%, p = 0.06).
The variability of QTc values depending on used correc-
tion formula was assessed in whole population and within 
each group (Table 3). QTc interval obtained with Hodges 
formula was the longest. Significant differences were fou-
nd between values of QTc interval obtained with Hodges, 
Framingham and Fridericia formulas in analysis for all pa-
tients and group non-D, but not in group D.
Relationship of the QTc internal  
with the selected clinical parameters
No significant correlations were found between QTc interval 
and potassium, sodium, calcium levels as well as weight 
and body mass index (BMI). QT interval corrected with Ba-
zett and Hodges formulas was significantly dependent on 
heart rate: R = –0.29, p = 0.03 and R = –0.42, p = 0.001, 
Table 1. Demographic and clinical characteristic of study population stratified by drugs that prolong QT*







Age (years) 21.5 (19–25) 20 (19–24.5) 23 (18.5–30) NS
Male sex 2 (3.57%) 1 (2.23%) 1 (8.3%) NS
Weight [kg] 35.6 (31.7–40.1) 35.7 (31.6–40.2) 35.8 (32–38.9) NS
BMI [kg/m2] 12.75 (11.5–15.6) 12.9 (11.5–15.7) 12.6 (11.7–14.9) NS
HR [bpm] 57 (47–75) 58 (49–75) 68 (47–75) NS
HR < 50 [bpm] 18 (32.1%) 13 (29.5%) 5 (41.7%) NS
SBP < 90 [mm Hg] 24 (43.6%) 20 (45.5%) 4 (50%) NS
WBC [×103/µL] 4.4 (3.6–5.7) 4.2 (3.5–5.4) 4.9 (3.7–7.3) NS
Hemoglobin [g/dL] 12.3 (11.3–13.3) 12.3 (11.4–13.2) 12.2 (10.1–14.6) NS
Sodium [mmol/L] 140 (138–142) 141 (139–144) 138.5 (134.8–140) 0.02
Potassium [mmol/L] 4 (3.7–4.3) 4 (3.7–4.6) 3.9 (3.5–4.0) NS
Hypokalemia 11 (19.6%) 8 (18.2%) 3 (25%) NS
Phosphate [mg/dL] 3.15 ± 1.04 3.24 ± 1.07 3.05 ± 1.12 NS
Total calcium [mg/dL] 9.24 ± 0.87 9.28 ± 0.86 8.95 ± 1.38 NS
Ionized calcium [mg/dL] 1.24 ± 0.04 1.24 ± 0.05 1.23 ± 0.03 NS
TSH [mIU/L] 1.95 (1.39–2.76) 1.86 (1.17–2.76) 1.99 (1.56–2.8) NS
Total protein [g/dL] 6.48 ± 0.9 6.4 ± 0.86 6.74 ± 1.01 NS
Glucose [mg/dL] 75 (69–83) 75 (68–81) 80 (71.5–91.5) 0.03
Total cholesterol [mg/dL] 168 (131–194) 169 (131–192) 156 (109–261) NS
HDL [mg/dL] 67.2 ± 21.1 66.4 ± 20.4 69.8 ± 24 NS
LDL [mg/dL] 85 (58–124) 84 (62–113) 102 (32–145) NS
Triglyceride [mg/dL] 76.5 (55–125) 78 (58–138) 74 (54–82) NS
Data are presented as mean ± standard deviation (SD), median (1 to 3 boundaries) or number (percentage). All measurements are taken at admission; n — number; NS — not significant; BMI — body mass 
index; HR— heart rate; SBP — systolic blood pressure; WBC — white blood count; TSH — thyroid-stimulating hormone; HDL — high-density lipoprotein; LDL — low-density lipoprotein
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respectively. Influence of heart rate on results of Fridericia 
and Framingham formulas was not significantly important 
(R = –0.22, p = 0.1 and R = –0.11, p = 0.4). See Table 4.
Discussion
The present study focused on analysis of QTc interval in 
patients suffered from AN depending on pharmacological 
treatment. We used and compared four QT correction 
formulas: Bazett, Fridericia, Framingham and Hodges to 
find the most appropriate one for patients with AN. The 
QTc interval tended to be longer in patients, who were ad-
ministrated drugs with potential to prolong the myocardial 
repolarization (p value: 0.04–0.07, depending on used 
correction formula). The percentage of patients with pro-
long QTc (> 460 ms for women and > 450 ms for men) was 
depended on used formula and was greater in drug-group, 
when using Fridericia method.
There are several studies focused on the QT inter-
val in patients with AN and the results are inconsistent. 
QTc interval prolongation was observed in considerable 
amount of small studies [4, 14–20]. Majority of those stu-
dy used only Bazett formula, which is highly dependent on 
heart rate [21]. Another limitations were small samples 
and various upper limit of normal for QT interval. Most 
of novel studies are not in line with previous results and 
usually failed to prove higher prevalence of QTc interval 
prolongation in AN patients [22–27]. Bomba et al. [28] 
found reduced QTc interval in drug-free AN patients com-
pared to controls. What is worth to mention, majority of 
those studies assessed patients on drug and those wit-
hout treatment together, so influence of medication was 
not taken into account. Janzen at al. analyzed changes 
on the electrocardiogram in AN and considered impact of 
pharmacotherapy [29]. There were no differences in the 
QT interval and QTc with Hodges as well as T-wave abnor-
mality between drug-free and drug-on patients. Drug-free 
patients were compared to controls and results were de-
pendent on used formula — QTc interval in AN patients 
was shorter (Bazett, Fridericia), longer (Framingham) or 
similar (Hodges) than controls. Comparison between drug-
-on and drug-free patients was also conducted in study 
by Padfield et al. [26] — there was also no difference in 
QTc interval between these groups.
The choice of correction method is still not clear. Walter 
et al. suggested Hodges formula, because of lack of corre-
lation with heart rate in their study [27]. It is not consistent 
with our results, Bazett and Hodges formulas correlated 
Table 2. QT interval in group non-D and group D corrected with four formulas
Group non-D (n = 44) Group D (n = 12) p* p**




> 460 ms# 
N [%]








417 ± 35 350–500 5 (11.4%) 464 ± 92 383–698 2 (16.7%) 0.05 NS
Fridericia  
correction
416 ± 34 325–505 3 (6.8%) 465 ± 85 394–678 4 (33.3%) 0.06 0.03
Framingham 
correction
413 ± 33 335–505 3 (6.8%) 459 ± 81 391–665 3 (25%) 0.04 NS
Hodges  
correction
423 ± 36 339–532 4 (9.1%) 472 ± 82 393–660 4 (33.3%) 0.07 0.06
*Comparison between QTc intervals (ms) in both group; **comparison between number of prolonged QTc intervals in both group; #for men > 450 ms; n — number; NS — not significant; SD — standard deviation
Table 3. Comparison between QTc intervals depending on correction method
p value for whole population 
(n = 56)
p value for group non-D  
(n = 44)
p value for group D  
(n = 12)
QTc Bazett vs. QTc Fridericia NS NS NS
QTc Bazett vs. QTc Framingham NS NS NS
QTc Bazett vs. QTc Hodges NS NS NS
QTc Fridericia vs. QTc Framingham 0.001 0.008 0.07
QTc Fridericia vs. QTc Hodges < 0.001 < 0.001 NS
QTc Framingham vs. QTc Hodges 0.001 < 0.001 NS
NS — not significant
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significantly with heart rate in the present study. Hodges 
formula tended to overestimate QT duration. According to 
our results, Fridericia and Framingham were the least de-
pendent on heat rate, so they may be useful with patients 
with bradycardia. On the other hand, duration of QT interval 
corrected with Hodges, Fridericia and Framingham differed 
significantly, but when compared to Bazett method, the re-
sults were similar. The larger research is needed to estab-
lish if QT interval duration corrected with specific method 
have prognostic value in long-term follow-up.
Another finding was that in our study there was no re-
lationship between QTc interval and electrolytes or weight 
and BMI. Several studies reached similar conclusion [15, 
26, 30]. In contrary, Swenne et al. showed significant re-
lationship between QT value and BMI, weight and sodium 
concentration [18].
Study limitations
This is a retrospective, single center study. Main limitation 
is small number of patients, especially in group treated 
with drugs, which may prolong QT interval. We analyzed 
medication at the moment of the hospital admission, 
which reflected chronic treatment. There was variability 
of administrated drugs, which might affect myocardial 
repolarization, so group D was not homogenous. ECG was 
not reassessed after refeeding.
Conclusions
Information about pharmacotherapy in AN patient is key 
for QTc assessment. Choice of correction formula may have 
impact on results. Framingham and Fridericia formulas 
were the least dependent on heart rate in contrary to Bazett 
and Hodges formulas.
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Table 4. Correlation between QTc intervals and selected variables 
for whole population
Variable R Spearman p value






Total calcium –0.05 NS
Ionized calcium –0.14 NS
TSH –0.04 NS






Total calcium –0.12 NS
Ionized calcium –0.33 NS
TSH 0.1 NS






Total calcium –0.12 NS
Ionized calcium –0.3 NS
TSH 0.1 NS






Total calcium –0.17 NS
Ionized calcium –0.29 NS
TSH 0.12 NS
HR — heart rate; NS — not significant; BMI — body mass index; TSH — thyroid-stimulating hormone
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Streszczenie
Wstęp. Pacjenci z jadłowstrętem psychicznym (AN) są narażeni na zwiększone ryzyko komorowych zaburzeń rytmu, 
które wiąże się z wydłużeniem odstępu QT. Celem pracy była analiza odstępu QT u pacjentów z AN z uwzględnieniem 
potencjalnego wpływu farmakoterapii oraz weryfikacja różnych formuł korekcji QT.
Materiał i metody. Do analizy włączono 56 pacjentów hospitalizowanych z powodu AN (średni wiek: 22,8 ± 5,6 roku; 
kobiety/mężczyźni: 54/2, średni wskaźnik masy ciała = 13,6 ± 2,6 kg/m2): grupę nie-D (n = 44; 78,6%) stanowili cho-
rzy niestosujący leków wydłużających odstęp QT, a grupę D (n = 12; 21,4%) chorzy leczeni takimi lekami. Odstępy QT 
mierzono w 12-odprowadzeniowym zapisie elektrokardiograficznym i korygowano przy użyciu czterech wzorów: Bazetta, 
Fridericia, Framinghama i Hodgesa.
Wyniki. Średnia częstość rytmuserca (HR) była podobna w obu grupach (61 ± 16,3 bpm w grupie D vs. 63,1 ± 18,7 bpm 
w grupie nie-D; p > 0,05). Bradykardia (HR < 50 bpm) była obecna u 5 chorych (41,7%) w grupie D i 13 chorych (29,5%) 
w grupie nie-D. Odstęp QTc skorygowany z użyciem wzoru Framinghama był dłuższy w grupie D (459 ± 81 ms) niż w gru-
pie nie-D (413 ± 33 ms); p = 0,04. Odstęp QT skorygowany z użyciem wzorów Bazetta i Hodgesa był istotnie zależny od 
HR (odpowiednio R = –0,29, p = 0,03 i R = –0,42, p = 0,001). Wpływ HR na wyniki z wzorów Fridericia i Framinghama 
nie był istotny (R = –0,22, p = 0,1 i R = –0,11, p = 0,4).
Wnioski. Informacje na temat farmakoterapii u chorych na AN mają kluczowe znaczenie dla oceny QTc. Wybór wzoru ko-
rekcji wpływa na QTc. Odstępy QT uzyskane przy użyciu formuł Framinghama i Fridericia były najmniej zależne od tętna.
Słowa kluczowe: jadłowstręt psychiczny, częstość rytmu, wzory korekcji QT, odstęp QT, wydłużenie QT
Folia Cardiologica 2021; 16, 3: 155–161
References
1. Sachs KV, Harnke B, Mehler PS, et al. Cardiovascular complications of 
anorexia nervosa: a systematic review. Int J Eat Disord. 2016; 49(3): 
238–248, doi: 10.1002/eat.22481, indexed in Pubmed: 26710932.
2. Birmingham CL, Su J, Hlynsky JA, et al. The mortality rate from anore-
xia nervosa. Int J Eat Disord. 2005; 38(2): 143–146, doi: 10.1002/ 
/eat.20164, indexed in Pubmed: 16134111.
3. Panagiotopoulos C, McCrindle BW, Hick K, et al. Electrocardiograp-
hic findings in adolescents with eating disorders. Pediatrics. 2000; 
105(5): 1100–1105, doi: 10.1542/peds.105.5.1100, indexed in 
Pubmed: 10790469.
4. Cooke RA, Chambers JB, Singh R, et al. QT interval in anorexia nervo-
sa. Br Heart J. 1994; 72(1): 69–73, doi: 10.1136/hrt.72.1.69, inde-
xed in Pubmed: 8068473.
5. Lupoglazoff JM, Berkane N, Denjoy I, et al. [Cardiac consequences 
of adolescent anorexia nervosa]. Arch Mal Coeur Vaiss. 2001; 94(5): 
494–498, indexed in Pubmed: 11434018.
6. Janzen ML, Malhi N, Laksman ZWM, et al. The QT interval in anore-
xia nervosa: a meta-analysis. JACC Clin Electrophysiol. 2018; 4(6): 
839–841, doi: 10.1016/j.jacep.2018.01.019, indexed in Pubmed: 
29929679.
7. Giovinazzo S, Sukkar SG, Rosa GM, et al. Anorexia nervosa and 
heart disease: a systematic review. Eat Weight Disord. 2019; 24(2): 
199–207, doi: 10.1007/s40519-018-0567-1, indexed in Pubmed: 
30173377.
8. Woosley RL, Heise CW, Romero KA. QTdrugs List, 17.04.2020, 
AZCERT, Inc. 1822 Innovation Park Dr., Oro Valley, AZ 85755. www.
Crediblemeds.org (November 24, 2020).
9. Bazett HC. An analysis of the time relations of electrocardio-
grams. Ann Noninvasive Electrocardiol. 1997; 2(2): 177–194, doi: 
10.1111/j.1542-474x.1997.tb00325.x.
10. Fridericia LS. Die Systolendauer im Elektrokardiogramm bei norma-
len Menschen und bei Herzkranken. Acta Med Scand. 2009; 53(1): 
469–486, doi: 10.1111/j.0954-6820.1920.tb18266.x.
11. Sagie A, Larson MG, Goldberg RJ, et al. An improved method for adjus-
ting the QT interval for heart rate (the Framingham Heart Study). Am 
J Cardiol. 1992; 70(7): 797–801, doi: 10.1016/0002-9149(92)90562-d, 
indexed in Pubmed: 1519533.
12. Hodges M, Salerno D, Erlien D. Bazett’s QT correction reviewed: evi-
dence that a linear QT correction for heart rate is better. J Am Coll 
Cardiol. 1983; 1: 694.
13. Rautaharju PM, Surawicz B, Gettes LS, et al. American Heart Association 
Electrocardiography and Arrhythmias Committee, Council on Clinical Car-
diology, American College of Cardiology Foundation, Heart Rhythm Socie-
ty. AHA/ACCF/HRS recommendations for the standardization and inter-
pretation of the electrocardiogram: part IV: the ST segment, T and U wa-
ves, and the QT interval: a scientific statement from the American Heart 
Association Electrocardiography and Arrhythmias Committee, Council on 
Clinical Cardiology; the American College of Cardiology Foundation; and 
the Heart Rhythm Society. Endorsed by the International Society for Com-
puterized Electrocardiology. J Am Coll Cardiol. 2009; 53(11): 982–991, 
doi: 10.1016/j.jacc.2008.12.014, indexed in Pubmed: 19281931.
14. Duraković Z, Duraković A, Korsić M. Changes of the corrected Q-T 
interval in the electrocardiogram of patients with anorexia nervosa. Int 
J Cardiol. 1994; 45(2): 115–120, doi: 10.1016/0167-5273(94)90266-6, 
indexed in Pubmed: 7960249.
15. Galetta F, Franzoni F, Cupisti A, et al. QT interval dispersion in young 
women with anorexia nervosa. J Pediatr. 2002; 140(4): 456–460, 
doi: 10.1067/mpd.2002.122726, indexed in Pubmed: 12006961.
16. Guerrier K, Mitan L, Wang Yu, et al. Risk for prolonged QT inter-
val and associated outcomes in children with early restrictive ea-
161www.journals.viamedica.pl/folia_cardiologica
Karol Głowacki et al., QTc interval in anorexia nervosa
ting patterns. Cardiol Young. 2016; 26(4): 644–649, doi: 10.1017/ 
/S1047951115000785, indexed in Pubmed: 26032968.
17. Palla B, Litt IF. Medical complications of eating disorders in adole-
scents. Pediatrics. 1988; 81(5): 613–623, indexed in Pubmed: 
3162764.
18. Swenne I, Larsson PT. Heart risk associated with weight loss in an-
orexia nervosa and eating disorders: risk factors for QTc interval 
prolongation and dispersion. Acta Paediatr. 2007; 88(3): 304–309, 
doi: 10.1111/j.1651-2227.1999.tb01101.x.
19. Takimoto Y, Yoshiuchi K, Kumano H, et al. QT interval and QT disper-
sion in eating disorders. Psychother Psychosom. 2004; 73(5): 324– 
–328, doi: 10.1159/000078850, indexed in Pubmed: 15292631.
20. Thurston J, Marks P. Electrocardiographic abnormalities in patients 
with anorexia nervosa. Br Heart J. 1974; 36(7): 719–723, doi: 
10.1136/hrt.36.7.719, indexed in Pubmed: 4413202.
21. Chiladakis J, Kalogeropoulos A, Arvanitis P, et al. Heart rate-depen-
dence of QTc intervals assessed by different correction methods 
in patients with normal or prolonged repolarization. Pacing Clin 
Electrophysiol. 2010; 33(5): 553–560, doi: 10.1111/j.1540-
-8159.2009.02657.x, indexed in Pubmed: 20025715.
22. DiVasta AD, Walls CE, Feldman HA, et al. Malnutrition and hemody-
namic status in adolescents hospitalized for anorexia nervosa. Arch 
Pediatr Adolesc Med. 2010; 164(8): 706–713, doi: 10.1001/archpe-
diatrics.2010.138, indexed in Pubmed: 20679161.
23. Frederiksen TC, Krogh Christiansen M, Charmoth Østergaard P, et al. 
QTc interval and risk of cardiac events in adults with anorexia nervosa: 
a long-term follow-up study. Circ Arrhythm Electrophysiol. 2018; 11(8): 
e005995, doi: 10.1161/CIRCEP.117.005995, indexed in Pubmed: 
30030265.
24. Gottdiener JS, Gross HA, Henry WL, et al. Effects of self-induced star-
vation on cardiac size and function in anorexia nervosa. Circulation. 
1978; 58(3 Pt 1): 425–433, doi: 10.1161/01.cir.58.3.425, indexed 
in Pubmed: 679432.
25. Krantz MJ, Donahoo WT, Melanson EL, et al. QT interval dispersion 
and resting metabolic rate in chronic anorexia nervosa. Int J Eat 
Disord. 2005; 37(2): 166–170, doi: 10.1002/eat.20082, indexed in 
Pubmed: 15732074.
26. Padfield GJ, Escudero CA, DeSouza AM, et al. Characterization of 
myocardial repolarization reserve in adolescent females with anorexia 
nervosa. Circulation. 2016; 133(6): 557–565, doi: 10.1161/CIRCULA-
TIONAHA.115.016697, indexed in Pubmed: 26769740.
27. Walter C, Rottler E, von Wietersheim J, et al. QT-correction formulae 
and arrhythmogenic risk in female patients with anorexia nervosa. Int 
J Cardiol. 2015; 187: 302–303, doi: 10.1016/j.ijcard.2015.03.230, 
indexed in Pubmed: 25839627.
28. Bomba M, Tremolizzo L, Corbetta F, et al. QT interval and disper-
sion in drug-free anorexia nervosa adolescents: a case control study. 
Eur Child Adolesc Psychiatry. 2018; 27(7): 861–866, doi: 10.1007/ 
/s00787-017-1080-1, indexed in Pubmed: 29147785.
29. Janzen M, Cheung CC, Steinberg C, et al. Changes on the electrocar-
diogram in anorexia nervosa: a case control study. J Electrocardiol. 
2019; 56: 64–69, doi: 10.1016/j.jelectrocard.2019.07.006, indexed 
in Pubmed: 31319227.
30. Nahshoni E, Weizman A, Yaroslavsky A, et al. Alterations in QT disper-
sion in the surface electrocardiogram of female adolescents diagno-
sed with restricting-type anorexia nervosa. J Psychosom Res. 2007; 
62(4): 469–472, doi: 10.1016/j.jpsychores.2006.10.023, indexed in 
Pubmed: 17383499.
